Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

A woman with hair loss condition experienced rare hair color return, suggesting it might help diagnose the condition.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Methotrexate may help stabilize frontal fibrosing alopecia.

Over-the-counter hair growth products may cause frontal fibrosing alopecia due to allergens.

Sarcoidosis can mimic other skin disorders, making diagnosis challenging.

Early diagnosis and quick treatment improve life quality for FFA patients.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Titanium nanoparticles may trigger frontal fibrosing alopecia, so avoid products with them.

People with frontal fibrosing alopecia use sunscreen more due to increased sun damage, not because sunscreen causes their condition.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Repeated botulinum toxin injections for forehead wrinkles may cause hairline recession in some women.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.